Market capitalization | $102.70m |
Enterprise Value | $51.87m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 0.20 |
P/S ratio (TTM) P/S ratio | 0.40 |
P/B ratio (TTM) P/B ratio | 1.07 |
Dividend yield | 24.14% |
Last dividend (FY23) | $1.20 |
As a Free StocksGuide user, you can view scores for all 6,892 stocks worldwide.
2 Analysts have issued a PetMed Express, Inc. forecast:
2 Analysts have issued a PetMed Express, Inc. forecast:
Sep '24 |
+/-
%
|
||
Revenue | 259 259 |
4%
4%
|
|
Gross Profit | 64 64 |
9%
9%
|
|
EBITDA | 5.78 5.78 |
275%
275%
|
EBIT (Operating Income) EBIT | -1.27 -1.27 |
85%
85%
|
Net Profit | -0.96 -0.96 |
82%
82%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
PetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. The prescription medications include heartworm preventatives, arthritis, thyroid, diabetes and pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The firm markets its products through national television, online and direct mail or print advertising campaigns. The company was founded in January 1996 and is headquartered in Delray Beach, FL.
Head office | United States |
CEO | Sandra Campos |
Employees | 287 |
Founded | 1996 |
Website | www.1800petmeds.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.